Chang-Yun Lu
Overview
Explore the profile of Chang-Yun Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun M, Chang C, Lu C, Wu S, Zhang J
Nutrients
. 2022 May;
14(9).
PMID: 35565877
Purpose: Whether preexisting sarcopenia is an independent risk factor for cancer incidence remains unclear. Therefore, we performed this propensity score (PS)-matched (PSM) population-based cohort study to compare the incidence rate...
2.
Sun M, Chang C, Lu C, Wu S, Zhang J
J Pers Med
. 2022 Mar;
12(3).
PMID: 35330383
Purpose: The impact of tramadol analgesic use before breast cancer diagnosis on survival in patients with chronic pain is unclear. Therefore, we designed a propensity score-matched population-based cohort study to...
3.
Zhang J, Chang C, Lu C, Chen H, Wu S
Front Oncol
. 2022 Mar;
12:708632.
PMID: 35311108
Purpose: We examined locoregional recurrence (LRR) in patients with breast invasive ductal carcinoma (IDC) receiving total mastectomy (TM) under propofol-based paravertebral block-regional anesthesia (PB-RA) versus sevoflurane-based inhalational general anesthesia (INHA-GA)...
4.
Sun M, Chang C, Lu C, Zhang J, Wu S
Br J Anaesth
. 2022 Feb;
128(4):708-717.
PMID: 35144799
Background: The impact of opioid analgesic use before cancer diagnosis on survival in patients with chronic pain is unclear. Therefore, we designed a propensity score-matched population-based cohort study to compare...
5.
Zhang J, Chang C, Lu C, Chen H, Wu S
Am J Cancer Res
. 2021 Nov;
11(10):4966-4980.
PMID: 34765304
To estimate oncologic outcomes (overall survival [OS], locoregional recurrence [LRR], and distant metastasis [DM]) in patients with breast intraductal carcinoma (IDC) receiving breast conserving surgery (BCS) under propofol-based total intravenous...
6.
Zhang J, Chang C, Lu C, Chen H, Wu S
Biomed Pharmacother
. 2021 Aug;
142:111991.
PMID: 34449311
Purpose: We examined locoregional recurrence (LRR) in patients with breast invasive ductal carcinoma (IDC) receiving breast conservative surgery (BCS) under propofol-based paravertebral block-regional anesthesia (PB-RA) versus sevoflurane-based inhalational general anesthesia...
7.
Zhang J, Lu C, Chen H, Wu S
JAMA Netw Open
. 2021 Mar;
4(3):e211785.
PMID: 33710293
Importance: Although neoadjuvant endocrine therapy (NET) is an alternative to chemotherapy for strongly hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (ERBB2)-negative breast cancer, evidence is currently lacking...
8.
Zhang J, Lu C, Chen H, Wu S
Surg Oncol
. 2020 Dec;
36:91-98.
PMID: 33316685
Purpose: To determine easy-to-use predictors of overall survival (OS), locoregional recurrence (LRR), and distant metastasis (DM) in patients with breast invasive ductal carcinoma (IDC) receiving neoadjuvant chemotherapy (NACT) followed by...
9.
Zhang J, Sun M, Chang E, Lu C, Chen H, Wu S
Am J Cancer Res
. 2020 Nov;
10(10):3415-3427.
PMID: 33163280
To determine easy-to-use predictors of overall survival (OS), locoregional recurrence (LRR), and distant metastasis (DM) in breast invasive ductal carcinoma (IDC) patients receiving neoadjuvant chemotherapy (NACT) and total mastectomy (TM),...
10.
Zhang J, Lu C, Qin L, Chen H, Wu S
Breast
. 2020 Oct;
54:139-147.
PMID: 33049657
Purpose: To investigate the outcomes of adjuvant whole breast radiation therapy (WBRT) in patients with invasive ductal carcinoma of the breast (breast IDC) receiving preoperative systemic therapy (PST) and breast-conserving...